News - Evotec Website (English)
3 days ago · It is a prime concern of Evotec that all relevant target groups receive the same information at the same time. This implies communicating in both English and German. Here you will find the most recent corporate news, ad hoc releases and other announcements of …
Investor Relations & Evotec News - Evotec Website (English)
IR & News Welcome to the Evotec newsroom. Here you can find all Investor Relations information, which events Evotec will be attending, all recent new releases and sign up for regular scientific updates.
Evotec announces change in Management Board
Sep 3, 2024 · Evotec SE today announced that its Chief Business Officer, Dr Matthias Evers, has decided to step down to pursue opportunities outside of Evotec. He will leave the Company effective 01 October 2024. Matthias was appointed Chief Business Officer of …
Together for Medicines That Matter - Evotec Website (English)
Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.
Evotec reports Q1 2024 results and provides corporate update
May 22, 2024 · Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced financial results and corporate updates for the first quarter 2024. HIGHLIGHTS. EVOTEC’S TRANSACTIONAL BUSINESS IMPACTED BY HEADWINDS; STRONG GROWTH IN JUST – EVOTEC BIOLOGICS
Evotec SE reports H1 2024 results: Challenging year; priority reset …
Aug 14, 2024 · Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Evotec and Novo Nordisk enter into technology development …
Sep 26, 2024 · Under the collaboration agreement, Novo Nordisk will provide funding for technology development activities at Evotec’s R&D site in Göttingen, Germany and at Evotec’s certified cell therapy manufacturing facility in Modena, Italy.
Evotec Stock Information - Evotec Website (English)
Evotec intends to retain all available funds and any future earnings and reinvest them in the company’s further growth strategy to better leverage long-term growth and sustainability.
PerkinElmer to Acquire Evotec Technologies
Dec 1, 2006 · Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) yesterday evening announced that PerkinElmer Inc. (NYSE: PKI) signed a definitive agreement to acquire Evotec Technologies GmbH in a cash transaction valued at approximately EUR 23 million.
Investor Relations - Evotec Website (English)
The Investor Relations department of Evotec SE acts as an interface between the company and the capital markets. Our extensive investor relations work focuses on an active, regular, comprehensive and transparent dialogue with our stakeholders, including shareholders, existing and potential investors, analysts, banks and the financial press.